Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-24 · accession 0001493152-22-017786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-27 | 2022-06-24 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $9.13 | +22.5K | 2.71M | +0.8% | +$205.7K | |
| I | 2022-06-27 | 2022-06-24 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $9.13 | +6,465 | 2.71M | +0.2% | +$59.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-24 | P | A | 22,535 | $9.13 | 2,706,421 | D By Wife | — | — | |
| 2 | Common | Common Stock | 2022-06-24 | P | A | 6,465 | $9.13 | 2,712,886 | I | — | — |